Company intelligence / Profile preview

Rheonix

Ithaca, NY, United States

Ownership: Private
Development stage: Other

Overview

Rheonix commercializes fully automated molecular diagnostic platforms enabling rapid, low-cost, sample-to-answer workflows for detection of various diseases and food safety issues. Clinical validation results emphasize expedited nucleic acid analysis for a broad range of sample types, though detailed peer-reviewed clinical trial data is not publicly provided.

Therapeutic areas: CardiovascularInfectious DiseasesNeurologyRare DiseasesOtherOncology
Modalities: DeviceMolecular diagnostic assayMicrofluidics device
Industry: Molecular Diagnostics

Partnerships

University at Buffalo Center of Excellence in Bioinformatics and Life SciencesVarious academic research centers

Beyond the preview

Go deeper on Rheonix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rheonix.

Explore the full profile